ப்ரொஃபெஸர் பால் ஹாரிசன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ரொஃபெஸர் பால் ஹாரிசன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ரொஃபெஸர் பால் ஹாரிசன் Today - Breaking & Trending Today

Catching Covid is EIGHT times more likely to trigger rare blood clot than having Oxford/AstraZeneca jab


Catching Covid is EIGHT times more likely to trigger rare blood clot than having Oxford/AstraZeneca jab
Chris Pollard
15 Apr 2021, 21:57
CATCHING Covid-19 is eight times more likely to trigger a rare blood clot than having the Oxford/AstraZeneca jab, scientists found.
Researchers at Oxford University found 39 in a million Covid patients suffered CVT a brain blood clot while it affected just five in a million people who were given the home-grown vaccine.

4
4
Catching Covid-19 is eight times more likely to trigger a rare blood clot than having the Oxford/AstraZeneca jab, scientists foundCredit: AFP
Coronavirus also causes other types of serious blood clots including strokes and PVT, which affects the liver. ....

United Kingdom , Paul Harrison , Oxford Astrazeneca , Nicola Sturgeon , Researchers At Oxford University , Oxford University , First Minister Nicola Sturgeon , Professor Paul Harrison , May Holyrood , ஒன்றுபட்டது கிஂக்டம் , பால் ஹாரிசன் , நிகோலா ஸ்டர்ஜன் , ஆராய்ச்சியாளர்கள் இல் ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் , முதல் அமைச்சர் நிகோலா ஸ்டர்ஜன் , ப்ரொஃபெஸர் பால் ஹாரிசன் , இருக்கலாம் ஹோலிரூட் ,

Blood-clotting illness PVT 30x more prevalent in Moderna, Pfizer Covid-19 recipients than AstraZeneca – Oxford researchers


Follow RT on
A potentially fatal blood-clotting disease is 30 times more common among people who have received the Covid-19 vaccines produced by Moderna and Pfizer than those given the troubled AstraZeneca jab, researchers have found.
A team of scientists from the University of Oxford has found that after vaccination, Vaxzevria (formerly AstraZeneca Covid-19 vaccine) recipients were less likely to suffer portal vein thrombosis (PVT) – blood clots in the artery from the intestines to the liver.
For recipients of the viral vector Vaxzevria vaccine, the incidence rate for splanchnic thrombosis – clotting in the portal and other abdominal veins – is 1.6 per million people, according to data from the EU drugs regulator the European Medicines Agency (EMA). By contrast, some 44.9 cases of PVT per million people were seen among those who had been injected with the mRNA vaccines made by Moderna and Pfizer, the Oxford research, published on Thursday, said. ....

Astrazeneca Covid , Paul Harrison , Maxime Taquet , University Of Oxford , Oxford Health Biomedical Research Centre , European Medicines Agency , University Department Of Psychiatry , Oxford University , Professor Paul Harrison , Health Biomedical Research Centre , பால் ஹாரிசன் , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் , ஆக்ஸ்ஃபர்ட் ஆரோக்கியம் உயிர் மருத்துவ ஆராய்ச்சி மையம் , பல்கலைக்கழகம் துறை ஆஃப் மனநல மருத்துவம் , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் , ப்ரொஃபெஸர் பால் ஹாரிசன் , ஆரோக்கியம் உயிர் மருத்துவ ஆராய்ச்சி மையம் ,

CVT risk from COVID-19 infection 'significantly higher' than from vaccines, study suggests


CVT risk from COVID-19 infection significantly higher than from vaccines, study suggests
The risk of cerebral venous thrombosis (CVT) following COVID-19 infection is eight to ten times higher than after receiving a COVID-19 vaccination, researchers have said.
by Emma Bower
Sign in to continue
Free email bulletins ....

Paul Harrison , Oxford Astrazeneca , University Of Oxford , European Medicine Agency , Translational Neurobiology Group , Professor Paul Harrison , பால் ஹாரிசன் , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் , ப்ரொஃபெஸர் பால் ஹாரிசன் ,

The FINANCIAL - Risk of rare blood clotting higher for COVID-19 than for vaccines


Share This
The FINANCIAL COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines. Researchers at the University of Oxford have today reported that the risk of the rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 infection is around 100 times greater than normal, several times higher than it is post-vaccination or following influenza, University of Oxford notes.
The study authors, led by Professor Paul Harrison and Dr Maxime Taquet from Oxford University’s Department of Psychiatry and the NIHR Oxford Health Biomedical Research Centre, counted the number of CVT cases diagnosed in the two weeks following diagnosis of COVID-19, or after the first dose of a vaccine. The then compared these to calculated incidences of CVT following influenza, and the background level in the general population. ....

Paul Harrison , Maxime Taquet , University Of Oxford , Head Of The Translational Neurobiology Group , Oxford University Department Of Psychiatry , Oxford Health Biomedical Research Centre , Translational Neurobiology Group , Professor Paul Harrison , Oxford University , Health Biomedical Research Centre , The Financial Covid 19 Leads Toa Several Times Higher Risk Of Cerebral Venous Thrombosis Cvt Blood Clots Than Current Vaccines Researchers At University Oxford Have Today Reported That Rare Clotting Known As Following Infection Is Around 100 Greater Normal , Everal Times Higher Than It Is Post Vaccination Or Following Influenza , Niversity Of Oxford Notes , பால் ஹாரிசன் , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் துறை ஆஃப் மனநல மருத்துவம் , ஆக்ஸ்ஃபர்ட் ஆரோக்கியம் உயிர் மருத்துவ ஆராய்ச்சி மையம் , ப்ரொஃபெஸர் பால் ஹாரிசன் , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் , ஆரோக்கியம் உயிர் மருத்துவ ஆராய்ச்சி மையம் ,